Inappropriate response against Hepatitis B vaccine in health personnel of the National Hospital, Paraguay.
DOI:
https://doi.org/10.31053/1853.0605.v75.n3.19060Keywords:
hepatitis B vaccine, anti-HBs, health personnelAbstract
Introduction: health personnel are a risk group for acquiring hepatitis B. The vaccine against it is effective but requires evaluation of the immune response with the dosage of anti-HBs.
Objectives: to determine the immunological response to the vaccine against hepatitis B in physicians, nurses and medical students of the National Hospital, Paraguay.
Methods: an observational, analytical and cross-sectional study was conducted in a sample of 120 health workers during 2017. The level of anti-HBs was determined with quantitative immunoassay and demographic and clinical variables were recorded, with prior informed consent.
Results: the sample was integrated with 79 women and 41 men. The mean age was 28±7 years. Physicians (62.5%), nurses (20%) and medical students (17.5%) were included. The mean BMI was 24.7 ± 3.8 kg/m2. Adequate serum levels of anti-HBs (> 100 IU / mL) were detected in 64% of the health personnel. Obesity was a factor associated with poor response to the vaccine (p 0.02). Sex, age, the time elapsed since the last dose and smoking were factors not significantly associated with the lack of response to the vaccine.
Conclusion: inadequate response to HB vaccine was found in 36%. Obesity was significantly associated with poor immunological response.
Downloads
References
European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017 Aug;67(2):370-398. https://www.easl.eu/medias/cpg/management-of-hepatitis-B-virus-infection/English-report.pdf
Tajiri K, Shimizu Y. Unsolved problems and future perspectives of hepatitis B virus vaccination. World J Gastroenterol. 2015 Jun 21;21(23):7074-83. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476869/pdf/WJG-21-7074.pdf
Weinbaum CM, Mast EE, Ward JW. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Hepatology. 2009 May;49(5 Suppl):S35-44. http://onlinelibrary.wiley.com/doi/10.1002/hep.22882/epdf
Pottie K, Greenaway C, Feightner J, Welch V, Swinkels H, Rashid M et al. Evidence-based clinical guidelines for immigrants and refugees. CMAJ. 2011 Sep 6;183(12):E824-925. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168666/pdf/183e824.pdf
Thudi K, Yadav D, Sweeney K, Behari J. Physicians infrequently adhere to hepatitis vaccination guidelines for chronic liver disease. PLoS One. 2013 Jul 26;8(7):e71124. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724808/pdf/pone.0071124.pdf
Roukens AH, Visser LG. Hepatitis B vaccination strategy in vaccine low and non-responders: a matter of quantity of quality? Hum Vaccin. 2011 Jun;7(6):654-7.
http://www.tandfonline.com/doi/pdf/10.4161/hv.7.6.14986?needAccess=true
Pérez-López JA, García-Elorriaga G, Del Rey-Pineda G, Manjarrez-Téllez B. Antibodies against hepatitis B after vaccination in health workers. Salud Publica Mex. 2011 May-Jun; 53(3): 205-6. http://www.scielosp.org/pdf/spm/v53n3/a03v53n3.pdf
Yao J, Qiu Y, Chen Y, Jiang Z, Shen L, Shan H, Dai X, Li Q, Liu Y, Ren W, Ren J. Optimal vaccination program for healthy adults in China. Hum Vaccin Immunother. 2015;11(10):2389-94. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635859/pdf/khvi-11-10-1053674.pdf
Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, Rodewald LE, Douglas JM Jr, Janssen RS, Ward JW; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep. 2006 Dec 8;55(RR-16):1-33. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5516a1.htm
Lopes MH, Sartori AM, Souza TV, Mascheretti M, Chaves Tdo S. Hepatitis B revaccination for healthcare workers who are anti-HBs-negative after receiving a primary vaccination series. Rev Soc Bras Med Trop. 2012 Oct;45(5):639-42. http://www.scielo.br/pdf/rsbmt/v45n5/v45n5a18.pdf
Davison SA, Strasser SI. Ordering and interpreting hepatitis B serology. BMJ. 2014 Apr 17; 348: g2522. http://www.bmj.com/bmj/section-pdf/756691?path=/bmj/348/7957/Practice.full.pdf
Chen W, Gluud C. Vaccines for preventing hepatitis B in health-care workers. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD000100. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD000100.pub3/epdf
Launay O, Floret D. Hepatitis B vaccination: a review. Med Sci (Paris). 2015 May;31(5):551-8. https://www.medecinesciences.org/articles/medsci/pdf/2015/06/medsci20153105p551.pdf
Zhang L, Liu J, Lu J, Yan B, Song L, Li L, Cui F, Zhang G, Wang F, Liang X, Xu A. Antibody response to revaccination among adult non-responders to primary Hepatitis B vaccination in China. Hum Vaccin Immunother. 2015;11(11):2716-22. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685679/pdf/khvi-11-11-1045172.pdf
Walayat S, Ahmed Z, Daniel Martin, Puli S, Cashman M, Dhillon S. Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine. World J Hepatol 2015; 7(24): 2503-2509. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621464/pdf/WJH-7-2503.pdf
López N, Real Delor RE. Respuesta a la vacuna contra la hepatitis B en pacientes en hemodiálisis crónica. Rev Virtual Soc Parag Med Int 2016;3(1):22-32. http://www.revista.spmi.org.py/index.php/rvspmi/article/view/46/288
McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H, Hurlburt D, et al. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis. 2009 Nov 1;200(9):1390-6. https://academic.oup.com/jid/article-lookup/doi/10.1086/606119
Spradling PR, Xing J, Williams R, Masunu-Faleafaga Y, Dulski T, Mahamud A et al. Immunity to hepatitis B virus (HBV) infection two decades after implementation of universal infant HBV vaccination: association of detectable residual antibodies and response to a single HBV challenge dose. Clin Vaccine Immunol. 2013 Apr; 20(4): 559-61. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623410/pdf/zcd559.pdf
Nashibi R, Alavi SM, Yousefi F, Salmanzadeh S, Moogahi S, Ahmadi F, Farashahinejad M. Post-vaccination Immunity Against Hepatitis B Virus and Predictors for Non-responders Among Medical Staff. Jundishapur J Microbiol. 2015 Mar 21;8(3):e19579. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385250/pdf/jjm-08-03-19579.pdf
Young KM, Gray CM, Bekker LG. Is obesity a risk factor for vaccine non-responsiveness? PLoS One. 2013 Dec 11;8(12):e82779. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859613/pdf/pone.0082779.pdf
Ropero Álvarez AM, Pérez-Vilar S, Pacis-Tirso C, Contreras M, El Omeiri N, Ruiz-Matus C, Velandia-González M. Progress in vaccination towards hepatitis B control and elimination in the Region of the Americas. BMC Public Health. 2017 Apr 17;17(1):325. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392937/pdf/12889_2017_Article_4227.pdf
Acevedo G, Sanchez J, López L, Willington A, Burrone S, Farias A. Asociación de cobertura de vacunación con factores sociodemográficos, en trabajadores de centros de salud de primer nivel de atención, Córdoba-Argentina. Rev Fac Cien Med Univ Nac Cordoba. 2016;73(3):163-169. https://revistas.unc.edu.ar/index.php/med/article/view/14451/15369
Annunziata K, Rak A, Del Buono H, DiBonaventura M, Krishnarajah G. Vaccination rates among the general adult population and high-risk groups in the United States. PLoS One. 2012;7(11):e50553. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511565/pdf/pone.0050553.pdf
Assunção AÁ, Araújo TM, Ribeiro RB, Oliveira SV. Hepatitis B vaccination and occupation exposure in the healthcare sector in Belo Horizonte, Minas Gerais. Rev Saude Publica. 2012 Aug;46(4):665-73. http://www.scielo.br/pdf/rsp/v46n4/aop3554.pdf
Shokuhi Sh, Gachkar L, Alavi-Darazam I, Yuhanaee P, Sajadi M. Occupational Exposure to Blood and Body Fluids among Health Care Workers in Teaching Hospitals in Tehran, Iran. Iran Red Crescent Med J. 2012 Jul;14(7):402-7. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438432/pdf/ircmj-14-402.pdf
National Center for Immunization and Respiratory Diseases. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011 Jan 28;60(2):1-64. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6002a1.htm
Fainboim H, Marciano S, Di Benedetto N, Gadano A. Consenso argentino de hepatitis B. Acta Gastroenterol Latinoam. 2013 Mar;43(1):59-74. http://www.actagastro.org/numeros-anteriores/2013/Vol-43-N1/Vol43N1-PDF18.pdf
Zheng YB, Gu YR, Zhang M, Wang K, Huang ZL, Lin CS, Gao ZL. Health care workers in Pearl River Delta Area of China are not vaccinated adequately against hepatitis B: a retrospective cohort study. BMC Infect Dis. 2015 Nov 22;15:542. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655081/pdf/12879_2015_Article_1278.pdf
Zampino R, Boemio A, Sagnelli C, Alessio L, Adinolfi LE, Sagnelli E, Coppola N. Hepatitis B virus burden in developing countries. World J Gastroenterol. 2015 Nov 14;21(42):11941-53. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641116/pdf/WJG-21-11941.pdf
Downloads
Additional Files
- Carta al Editor (Español (España))
- Respuesta inadecuada a la vacuna contra la hepatitis B en personal de salud del Hospital Nacional, Paraguay (Español (España))
- Respuesta inadecuada a la vacuna contra la hepatitis B en personal de salud del Hospital Nacional, Paraguay (Español (España))
- Respuesta inadecuada a la vacuna contra la hepatitis B en personal de salud del Hospital Nacional, Paraguay (Español (España))
- Figura 1. Estados de protección contra hepatitis B en personal de salud (n 120) (Español (España))
Published
How to Cite
Issue
Section
License
The Faculty of Medical Sciences Journal (RFCM) subscribes to the Open Access policy and does not charge authors fees for publishing, nor does it charge readers fees for accessing published articles (APC).
